About Us
Current Events
Past Events
Video Gallery
Policy & Reports
Media Coverage
Contact Us

USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.

Registration is closed. Thanks for your overwhelming response. See you at 2021 summit- June 22. Marriott Cambridge, Massachusetts, USA
14th Annual BioPharma & Healthcare Summit, Friday, September 4, 2020, 8 AM EST to 3-30 PM EST - Virtual Edition
Registration is closed
The Summit has reached full capacity. Registration is closed. There is no onsite registration.
Thanks for your overwhelming response. See you at 2020 summit!

Chair and Master of Ceremonies (Emcee)– Dr. Andrew Plump, President of R&D, Takeda Pharmaceuticals

Timings are Eastern Standard Time (EST)

Time Topic
8 AM - 8-10 AM Welcome address: Karun Rishi, President, USAIC

Opening comments: Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals
8-10 AM - 8-50 AM Panel Discussion- COVID-19: Where are we now? Where are we going?

Dr. Barry Bloom, Professor & former Dean, Harvard School of Public Health
Dr. George Yancopoulos, Co-Founder, President & CSO, Regeneron
Kiran Mazumdar-Shaw, Executive Chairperson, Biocon
Dr. Rajeev Venkayya, President of the Global Vaccine Business Unit, Takeda
Dr. Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations (CEPI)

Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School
8-50 AM - 8-55 AM Polling + Break
8-55 AM - 9-10 AM India Regulatory update

Dr. Mandeep Bhandari, Joint Secretary, Ministry of Health & Family Welfare, India
Dr. V G Somani, Drug Controller General of India, Central Drug Control Organization

Muna Bhanji, Senior Vice President,  Merck & Co.
9-10 AM - 9-15 AM Polling + Break
9-15 AM - 9-55 AM Fireside Chat

Kenneth Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co.

Dr. Stelios Papadopoulos, Chairman of the Board, Biogen
9-55 AM - 10 AM Polling + Break
10 AM - 10-40 AM India Innovation Landscape

Amitabh Kant, Chief Executive Officer, National Institution for Transforming India (NITI)
Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group
Dr. K. Vijay Raghavan, Principal Scientific Advisor, Government of India
Dr. Naresh Trehan, Chairman, Medanta - the Medicity

Sanat Chattopadhyay, President, Merck Manufacturing Division; Merck & Co.
10-40 AM - 10-45 AM Polling + Break
10-45 AM - 11-25 AM Panel Discussion- Oncology: Changing landscape- COVID learnings and the promise of new technologies

Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic
Dr. Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute
Dr. Philip Larsen, Global Head of Research, Bayer AG
Rehan Verjee, President, EMD Serono
Dr. Tony Ho, Head of Research and Development, CRISPR Therapeutics

Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School
11-25 AM - 11-30 AM Polling + Break
11-30 AM - 12-10 PM Panel Discussion- Industry & Investment Outlook

Christopher Viehbacher, Managing Partner, Gurnet Point Capital
Daphne Zohar, Founder & CEO, PureTech Health
Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University
Dr. Stelios Papadopoulos, Chairman, Biogen

Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals
12-10 PM - 12-20 PM Polling + Break
12-20 PM - 1 PM Panel Discussion- Rare Diseases: No longer forgotten; but more to be achieved

Dr. Alfred Sandrock, Executive Vice President, Research & Development, Biogen
Dr. Daniel Curran, Head of the Rare Diseases Therapeutic Area Unit, Takeda
Dr. David Meeker, Chairman & CEO , Rhythm Pharmaceuticals
Dr. John Orloff, Head of Research & Development, Alexion
Matt Wilsey, Co-Founder & Chairman, Grace Science Foundation

Dr. Steve Uden, Co-Founder, Rallybio
1 PM - 1-05 PM Polling + Break
1-05 PM - 1-50 PM Fireside Chat

Dr. Roy Vagelos, Chairman of the Board, Regeneron Pharmaceuticals

Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson
1-50 PM - 1-55 PM Polling + Break
1-55 PM - 2-35 PM Panel Discussion- Digital & Data Science in Healthcare: Pragmatic Insights from the Real-World

Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals
Arpa Garay, President, Global Pharmaceuticals, Commercial Analytics, Merck & Co.
Dr. Maya Said, Chief Executive Officer, Outcomes4Me
Dr. Najat Khan, Chief Operating Officer, Janssen R&D Data Sciences, Johnson & Johnson
Nina Kjellson, General Partner, Canaan

Sastry Chilukuri, President, Acorn AI- Medidata
2-35 PM - 2-40 PM Polling + Break
2-40 PM - 3-20 PM Panel Discussion- R&D Strategies and Trends: Innovation- The Big I

Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals
Dr. David Reese, Executive Vice President, Research and Development, Amgen
Dr. Hal Barron, Chief Scientific Officer and President R&D, GlaxoSmithKline
Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson

Dr. Martin Mackay, Co-Founder, Rallybio
3-20 PM - 3-30 PM Closing Remarks

*Speaker and Timings subject to change      

Pharmasia News   Biospectrum India Online

© 2007 - USA India Chamber of Commerce Home | About us | | Policy | Events | Photo Gallery | Awards | Membership | Media Coverage | | Legal | Contact us